Overactive bladder – 18 years – part I

Detalhes bibliográficos
Autor(a) principal: Truzzi,Jose Carlos
Data de Publicação: 2016
Outros Autores: Gomes,Cristiano Mendes, Bezerra,Carlos A., Plata,Ivan Mauricio, Campos,Jose, Garrido,Gustavo Luis, Almeida,Fernando G., Averbeck,Marcio Augusto, Fornari,Alexandre, Salazar,Anibal, Dell'Oro,Arturo, Cintra,Caio, Sacomani,Carlos Alberto Ricetto, Tapia,Juan Pablo, Brambila,Eduardo, Longo,Emilio Miguel, Rocha,Flavio Trigo, Coutinho,Francisco, Favre,Gabriel, Garcia,José Antonio, Castaño,Juan, Reyes,Miguel, Leyton,Rodrigo Eugenio, Ferreira,Ruiter Silva, Duran,Sergio, López,Vanda, Reges,Ricardo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: International Braz J Urol (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382016000200188
Resumo: ABSTRACT Abstract: Overactive bladder syndrome is one of the lower urinary tract dysfunctions with the highest number of scientific publications over the past two decades. This shows the growing interest in better understanding this syndrome, which gathers symptoms of urinary urgency and increased daytime and nighttime voiding frequency, with or without urinary incontinence and results in a negative impact on the quality of life of approximately one out of six individuals – including both genders and almost all age groups. The possibility of establishing the diagnosis just from clinical data made patients' access to specialized care easier. Physiotherapy resources have been incorporated into the urological daily practice. A number of more selective antimuscarinic drugs with consequent lower adverse event rates were released. Recently, a new class of oral drugs, beta-adrenergic agonists has become part of the armamentarium for Overactive Bladder. Botulinum toxin injections in the bladder and sacral neuromodulation are routine modalities of treatment for refractory cases. During the 1st Latin-American Consultation on Overactive Bladder, a comprehensive review of the literature related to the evolution of the concept, epidemiology, diagnosis, and management was conducted. This text corresponds to the first part of the review Overactive Bladder 18-years.
id SBU-1_f3c818cfdcc47c3d025ef25892329a17
oai_identifier_str oai:scielo:S1677-55382016000200188
network_acronym_str SBU-1
network_name_str International Braz J Urol (Online)
repository_id_str
spelling Overactive bladder – 18 years – part IOveractive BladderMuscarinic AntagonistsBeta-adrenergic agonistsBotulinum ToxinSacral neuromodulationUrodynamicsABSTRACT Abstract: Overactive bladder syndrome is one of the lower urinary tract dysfunctions with the highest number of scientific publications over the past two decades. This shows the growing interest in better understanding this syndrome, which gathers symptoms of urinary urgency and increased daytime and nighttime voiding frequency, with or without urinary incontinence and results in a negative impact on the quality of life of approximately one out of six individuals – including both genders and almost all age groups. The possibility of establishing the diagnosis just from clinical data made patients' access to specialized care easier. Physiotherapy resources have been incorporated into the urological daily practice. A number of more selective antimuscarinic drugs with consequent lower adverse event rates were released. Recently, a new class of oral drugs, beta-adrenergic agonists has become part of the armamentarium for Overactive Bladder. Botulinum toxin injections in the bladder and sacral neuromodulation are routine modalities of treatment for refractory cases. During the 1st Latin-American Consultation on Overactive Bladder, a comprehensive review of the literature related to the evolution of the concept, epidemiology, diagnosis, and management was conducted. This text corresponds to the first part of the review Overactive Bladder 18-years.Sociedade Brasileira de Urologia2016-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382016000200188International braz j urol v.42 n.2 2016reponame:International Braz J Urol (Online)instname:Sociedade Brasileira de Urologia (SBU)instacron:SBU10.1590/S1677-5538.IBJU.2015.0365info:eu-repo/semantics/openAccessTruzzi,Jose CarlosGomes,Cristiano MendesBezerra,Carlos A.Plata,Ivan MauricioCampos,JoseGarrido,Gustavo LuisAlmeida,Fernando G.Averbeck,Marcio AugustoFornari,AlexandreSalazar,AnibalDell'Oro,ArturoCintra,CaioSacomani,Carlos Alberto RicettoTapia,Juan PabloBrambila,EduardoLongo,Emilio MiguelRocha,Flavio TrigoCoutinho,FranciscoFavre,GabrielGarcia,José AntonioCastaño,JuanReyes,MiguelLeyton,Rodrigo EugenioFerreira,Ruiter SilvaDuran,SergioLópez,VandaReges,Ricardoeng2016-05-19T00:00:00Zoai:scielo:S1677-55382016000200188Revistahttp://www.brazjurol.com.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||brazjurol@brazjurol.com.br1677-61191677-5538opendoar:2016-05-19T00:00International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)false
dc.title.none.fl_str_mv Overactive bladder – 18 years – part I
title Overactive bladder – 18 years – part I
spellingShingle Overactive bladder – 18 years – part I
Truzzi,Jose Carlos
Overactive Bladder
Muscarinic Antagonists
Beta-adrenergic agonists
Botulinum Toxin
Sacral neuromodulation
Urodynamics
title_short Overactive bladder – 18 years – part I
title_full Overactive bladder – 18 years – part I
title_fullStr Overactive bladder – 18 years – part I
title_full_unstemmed Overactive bladder – 18 years – part I
title_sort Overactive bladder – 18 years – part I
author Truzzi,Jose Carlos
author_facet Truzzi,Jose Carlos
Gomes,Cristiano Mendes
Bezerra,Carlos A.
Plata,Ivan Mauricio
Campos,Jose
Garrido,Gustavo Luis
Almeida,Fernando G.
Averbeck,Marcio Augusto
Fornari,Alexandre
Salazar,Anibal
Dell'Oro,Arturo
Cintra,Caio
Sacomani,Carlos Alberto Ricetto
Tapia,Juan Pablo
Brambila,Eduardo
Longo,Emilio Miguel
Rocha,Flavio Trigo
Coutinho,Francisco
Favre,Gabriel
Garcia,José Antonio
Castaño,Juan
Reyes,Miguel
Leyton,Rodrigo Eugenio
Ferreira,Ruiter Silva
Duran,Sergio
López,Vanda
Reges,Ricardo
author_role author
author2 Gomes,Cristiano Mendes
Bezerra,Carlos A.
Plata,Ivan Mauricio
Campos,Jose
Garrido,Gustavo Luis
Almeida,Fernando G.
Averbeck,Marcio Augusto
Fornari,Alexandre
Salazar,Anibal
Dell'Oro,Arturo
Cintra,Caio
Sacomani,Carlos Alberto Ricetto
Tapia,Juan Pablo
Brambila,Eduardo
Longo,Emilio Miguel
Rocha,Flavio Trigo
Coutinho,Francisco
Favre,Gabriel
Garcia,José Antonio
Castaño,Juan
Reyes,Miguel
Leyton,Rodrigo Eugenio
Ferreira,Ruiter Silva
Duran,Sergio
López,Vanda
Reges,Ricardo
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Truzzi,Jose Carlos
Gomes,Cristiano Mendes
Bezerra,Carlos A.
Plata,Ivan Mauricio
Campos,Jose
Garrido,Gustavo Luis
Almeida,Fernando G.
Averbeck,Marcio Augusto
Fornari,Alexandre
Salazar,Anibal
Dell'Oro,Arturo
Cintra,Caio
Sacomani,Carlos Alberto Ricetto
Tapia,Juan Pablo
Brambila,Eduardo
Longo,Emilio Miguel
Rocha,Flavio Trigo
Coutinho,Francisco
Favre,Gabriel
Garcia,José Antonio
Castaño,Juan
Reyes,Miguel
Leyton,Rodrigo Eugenio
Ferreira,Ruiter Silva
Duran,Sergio
López,Vanda
Reges,Ricardo
dc.subject.por.fl_str_mv Overactive Bladder
Muscarinic Antagonists
Beta-adrenergic agonists
Botulinum Toxin
Sacral neuromodulation
Urodynamics
topic Overactive Bladder
Muscarinic Antagonists
Beta-adrenergic agonists
Botulinum Toxin
Sacral neuromodulation
Urodynamics
description ABSTRACT Abstract: Overactive bladder syndrome is one of the lower urinary tract dysfunctions with the highest number of scientific publications over the past two decades. This shows the growing interest in better understanding this syndrome, which gathers symptoms of urinary urgency and increased daytime and nighttime voiding frequency, with or without urinary incontinence and results in a negative impact on the quality of life of approximately one out of six individuals – including both genders and almost all age groups. The possibility of establishing the diagnosis just from clinical data made patients' access to specialized care easier. Physiotherapy resources have been incorporated into the urological daily practice. A number of more selective antimuscarinic drugs with consequent lower adverse event rates were released. Recently, a new class of oral drugs, beta-adrenergic agonists has become part of the armamentarium for Overactive Bladder. Botulinum toxin injections in the bladder and sacral neuromodulation are routine modalities of treatment for refractory cases. During the 1st Latin-American Consultation on Overactive Bladder, a comprehensive review of the literature related to the evolution of the concept, epidemiology, diagnosis, and management was conducted. This text corresponds to the first part of the review Overactive Bladder 18-years.
publishDate 2016
dc.date.none.fl_str_mv 2016-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382016000200188
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382016000200188
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1677-5538.IBJU.2015.0365
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Urologia
publisher.none.fl_str_mv Sociedade Brasileira de Urologia
dc.source.none.fl_str_mv International braz j urol v.42 n.2 2016
reponame:International Braz J Urol (Online)
instname:Sociedade Brasileira de Urologia (SBU)
instacron:SBU
instname_str Sociedade Brasileira de Urologia (SBU)
instacron_str SBU
institution SBU
reponame_str International Braz J Urol (Online)
collection International Braz J Urol (Online)
repository.name.fl_str_mv International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)
repository.mail.fl_str_mv ||brazjurol@brazjurol.com.br
_version_ 1750318074594066433